Works in European Journal of Nuclear Medicine & Molecular Imaging, 2023, Vol 50, Issue 10
Results: 33
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2935, doi. 10.1007/s00259-023-06338-6
- By:
- Publication type:
- Article
PET imaging of tumor vascular normalization in hepatocellular carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2940, doi. 10.1007/s00259-023-06337-7
- By:
- Publication type:
- Article
Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2950, doi. 10.1007/s00259-023-06325-x
- By:
- Publication type:
- Article
PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2927, doi. 10.1007/s00259-023-06308-y
- By:
- Publication type:
- Article
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3157, doi. 10.1007/s00259-023-06304-2
- By:
- Publication type:
- Article
Correction to: One‑stop [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga‑DOTA‑FAPI‑04 total‑body PET/CT examination with dual‑low activity: a feasibility study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Response to: GCP III is not the "off-target" for urea-based PSMA-ligands.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2947, doi. 10.1007/s00259-023-06302-4
- By:
- Publication type:
- Article
A prospective head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3126, doi. 10.1007/s00259-023-06283-4
- By:
- Publication type:
- Article
Development and external validation of a multivariable [<sup>68</sup>Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3137, doi. 10.1007/s00259-023-06278-1
- By:
- Publication type:
- Article
Defining the role of nuclear medicine in haematological tumours—EANM Focus 4: consensus on molecular imaging and therapy in haematological tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2925, doi. 10.1007/s00259-023-06276-3
- By:
- Publication type:
- Article
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3050, doi. 10.1007/s00259-023-06272-7
- By:
- Publication type:
- Article
In vivo evaluation of a novel <sup>18</sup>F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2962, doi. 10.1007/s00259-023-06270-9
- By:
- Publication type:
- Article
GCP III is not the "off-target" for urea-based PSMA ligands.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2944, doi. 10.1007/s00259-023-06265-6
- By:
- Publication type:
- Article
Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[<sup>18</sup>F] fluoro-L-ascorbic acid PET imaging: first-in-human study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3072, doi. 10.1007/s00259-023-06262-9
- By:
- Publication type:
- Article
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3155, doi. 10.1007/s00259-023-06261-w
- By:
- Publication type:
- Article
Preclinical evaluation of <sup>68</sup>Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2952, doi. 10.1007/s00259-023-06260-x
- By:
- Publication type:
- Article
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3022, doi. 10.1007/s00259-023-06259-4
- By:
- Publication type:
- Article
Melanin-targeted [<sup>18</sup>F]-PFPN PET imaging for prognosticating patients with melanoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3062, doi. 10.1007/s00259-023-06258-5
- By:
- Publication type:
- Article
The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with <sup>177</sup>Lu DOTATATE (LuTate).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2997, doi. 10.1007/s00259-023-06257-6
- By:
- Publication type:
- Article
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3034, doi. 10.1007/s00259-023-06256-7
- By:
- Publication type:
- Article
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3084, doi. 10.1007/s00259-023-06254-9
- By:
- Publication type:
- Article
A pharmacological imaging challenge based on <sup>11</sup>C-buprenorphine PET-MRI to explore the response to opioids in humans.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3153, doi. 10.1007/s00259-023-06253-w
- By:
- Publication type:
- Article
The predictive value of pretherapy [<sup>68</sup>Ga]Ga-DOTA-TATE PET and biomarkers in [<sup>177</sup>Lu]Lu-PRRT tumor dosimetry.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2984, doi. 10.1007/s00259-023-06252-x
- By:
- Publication type:
- Article
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3107, doi. 10.1007/s00259-023-06251-y
- By:
- Publication type:
- Article
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3116, doi. 10.1007/s00259-023-06248-7
- By:
- Publication type:
- Article
FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals' use.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3042, doi. 10.1007/s00259-023-06246-9
- By:
- Publication type:
- Article
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3011, doi. 10.1007/s00259-023-06245-w
- By:
- Publication type:
- Article
[<sup>18</sup>F]MFBG PET/CT outperforming [<sup>123</sup>I]MIBG SPECT/CT in the evaluation of neuroblastoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3097, doi. 10.1007/s00259-023-06221-4
- By:
- Publication type:
- Article
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2921, doi. 10.1007/s00259-023-06244-x
- By:
- Publication type:
- Article
Metastatic melanoma extending along the inferior vena cava to its branches and venous plexus: a rare route metastasis characterized by [<sup>18</sup>F]FDG PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3149, doi. 10.1007/s00259-023-06238-9
- By:
- Publication type:
- Article
Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3151, doi. 10.1007/s00259-023-06237-w
- By:
- Publication type:
- Article
Bladder paraganglioma detection with [<sup>18</sup>F]MFBG PET/CT: a superior alternative to [<sup>68</sup>Ga]Ga-DOTATATE.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3147, doi. 10.1007/s00259-023-06233-0
- By:
- Publication type:
- Article
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 2971, doi. 10.1007/s00259-023-06240-1
- By:
- Publication type:
- Article